Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion

Purpose. To evaluate whether treatment with intravitreal corticosteroid and anti-vascular endothelial growth factor (VEGF) injections alternately can improve treatment outcomes of macular edema (ME) caused by retinal vein occlusion (RVO). Methods. This dual-center retrospective study included 112 ey...

Full description

Saved in:
Bibliographic Details
Main Authors: Young Hwan Bae, Seong Mi Kim, Jin Young Kim, So Hyun Bae, Hakyoung Kim, Dae Joong Ma
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/5948113
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524663388209152
author Young Hwan Bae
Seong Mi Kim
Jin Young Kim
So Hyun Bae
Hakyoung Kim
Dae Joong Ma
author_facet Young Hwan Bae
Seong Mi Kim
Jin Young Kim
So Hyun Bae
Hakyoung Kim
Dae Joong Ma
author_sort Young Hwan Bae
collection DOAJ
description Purpose. To evaluate whether treatment with intravitreal corticosteroid and anti-vascular endothelial growth factor (VEGF) injections alternately can improve treatment outcomes of macular edema (ME) caused by retinal vein occlusion (RVO). Methods. This dual-center retrospective study included 112 eyes with treatment-naïve ME secondary to RVO that were alternately treated with intravitreal corticosteroid and anti-VEGF injections (33 eyes, alternate group) or treated only with intravitreal anti-VEGF injections (79 eyes, anti-VEGF group) on a pro re nata basis. Results. During the 12-month follow-up period, the alternate group achieved a visual acuity gain of 0.39 logMAR, while the anti-VEGF group achieved a gain of 0.21 logMAR (P=0.042). The alternate group demonstrated a reduction in the central macular thickness of 229.9-μm, while the anti-VEGF group achieved a reduction of 220.1 μm (P=0.887). The alternate group required an average of 5.2 injections, while the anti-VEGF received 4.2 injections (P<0.001). In a propensity score-matched cohort to compensate for the differences in the injection numbers between the two groups, the alternate group achieved a better visual acuity gain than the anti-VEGF group at month 12 (0.39 logMAR vs. 0.17 logMAR, P=0.048). Conclusions. In ME secondary to RVO, treatment with intravitreal corticosteroid and anti-VEGF injections alternately resulted in a more favorable visual outcome compared with intravitreal anti-VEGF monotherapy.
format Article
id doaj-art-c9ddd28d0b864c3899b0933ae5122adc
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-c9ddd28d0b864c3899b0933ae5122adc2025-02-03T05:47:40ZengWileyJournal of Ophthalmology2090-004X2090-00582021-01-01202110.1155/2021/59481135948113Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein OcclusionYoung Hwan Bae0Seong Mi Kim1Jin Young Kim2So Hyun Bae3Hakyoung Kim4Dae Joong Ma5Department of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Jeju National University College of Medicine, Jeju-si, Jeju-do, Republic of KoreaDepartment of Ophthalmology, Jeju National University College of Medicine, Jeju-si, Jeju-do, Republic of KoreaDepartment of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaPurpose. To evaluate whether treatment with intravitreal corticosteroid and anti-vascular endothelial growth factor (VEGF) injections alternately can improve treatment outcomes of macular edema (ME) caused by retinal vein occlusion (RVO). Methods. This dual-center retrospective study included 112 eyes with treatment-naïve ME secondary to RVO that were alternately treated with intravitreal corticosteroid and anti-VEGF injections (33 eyes, alternate group) or treated only with intravitreal anti-VEGF injections (79 eyes, anti-VEGF group) on a pro re nata basis. Results. During the 12-month follow-up period, the alternate group achieved a visual acuity gain of 0.39 logMAR, while the anti-VEGF group achieved a gain of 0.21 logMAR (P=0.042). The alternate group demonstrated a reduction in the central macular thickness of 229.9-μm, while the anti-VEGF group achieved a reduction of 220.1 μm (P=0.887). The alternate group required an average of 5.2 injections, while the anti-VEGF received 4.2 injections (P<0.001). In a propensity score-matched cohort to compensate for the differences in the injection numbers between the two groups, the alternate group achieved a better visual acuity gain than the anti-VEGF group at month 12 (0.39 logMAR vs. 0.17 logMAR, P=0.048). Conclusions. In ME secondary to RVO, treatment with intravitreal corticosteroid and anti-VEGF injections alternately resulted in a more favorable visual outcome compared with intravitreal anti-VEGF monotherapy.http://dx.doi.org/10.1155/2021/5948113
spellingShingle Young Hwan Bae
Seong Mi Kim
Jin Young Kim
So Hyun Bae
Hakyoung Kim
Dae Joong Ma
Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
Journal of Ophthalmology
title Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
title_full Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
title_fullStr Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
title_full_unstemmed Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
title_short Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
title_sort effect of alternate treatment with intravitreal corticosteroid and anti vegf for macular edema secondary to retinal vein occlusion
url http://dx.doi.org/10.1155/2021/5948113
work_keys_str_mv AT younghwanbae effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion
AT seongmikim effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion
AT jinyoungkim effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion
AT sohyunbae effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion
AT hakyoungkim effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion
AT daejoongma effectofalternatetreatmentwithintravitrealcorticosteroidandantivegfformacularedemasecondarytoretinalveinocclusion